monoclon
antibodi
produc
hybrid
cell
line
rais
new
world
speci
leishmania
see
mcmahonpratt
david
use
particular
identifi
subspeci
l
braziliensi
see
mcmahonpratt
et
al
recent
studi
shown
monoclon
antibodi
could
kill
parasit
cultur
within
macrophag
vitro
induc
mortalitv
recoidedin
one
seri
experi
major
pathogen
agent
old
world
leishmaniasi
handman
hock
complet
protect
l
mexicana
amazon
protiastigot
inocul
monoclon
antibodi
similarli
obtain
viva
use
winn
assay
system
anderson
et
ae
data
piesent
show
singl
monoclon
antibodv
abl
orotect
balbk
mous
infect
eith
l
major
l
mexicana
amazonensi
monoclon
antibodi
produc
describ
els
roseto
et
al
monjour
et
al
use
leishmania
isol
greec
l
infantum
lem
montpelli
collect
bone
marrow
sick
dog
inject
hamster
amastigot
hamster
spleen
deposit
liquid
medium
medium
supplement
foetal
calf
serum
transform
promastigot
c
parasit
passag
twice
nutrient
broth
promastigot
prepar
use
immun
three
balbic
femal
mice
two
month
old
serolog
neg
leishmania
anim
inject
three
parasu
l
pg
quil
purifi
saponin
laboratori
time
day
subcutan
superfo
denmark
one
month
later
mous
highest
antileishmani
titr
given
booster
inject
x
promastigot
administ
intraperiton
four
day
cell
fusion
spleen
cell
mix
immunoglobulinnonsecret
azaguanineresist
mveloma
cell
shulman
et
al
fuse
poliethylen
glycol
follow
techniqu
describ
galfr
et
al
fuse
cell
select
hypoxanthineazaserin
ha
select
medium
screen
cell
cultur
supemat
perform
indirect
immunofluoresc
iif
monjour
et
al
l
infanturn
lem
l
major
l
amazonensi
use
antigen
mous
human
antileishmani
sera
normal
sera
rfmi
medium
use
control
posit
hybridoma
cultur
clone
use
limit
dilut
techniqu
mink
cell
american
type
cultur
collect
feeder
cell
supernat
erowin
clone
rescreen
bv
iif
clone
orov
z
po
select
highantibodi
titr
specif
monoclon
antibodi
secret
ten
clone
determin
indirect
immunofluoresc
test
describ
de
ibarra
et
al
larg
quantiti
antibodi
obtain
intraperiton
inject
x
hybridoma
cell
pristanetr
balbk
mice
two
week
later
ascit
fluid
recov
igg
class
determin
immunodiffus
method
one
ascit
fluid
iggzb
prove
posit
iif
l
infanturn
lem
l
major
lem
l
amazonensi
use
assay
protect
vivo
monoclonalantibodi
ascit
mix
promastigot
either
l
major
l
amazonensi
mixtur
maintain
min
inject
subcutan
near
root
tail
balbic
femal
mice
monoclon
antibodypromastigot
mixtur
observ
microscopi
inject
viabil
promastigot
base
motil
approxim
mani
control
use
condit
name
decompl
monoclon
antibodi
contain
ascit
mous
ascit
devoid
monoclon
antibodi
nonreact
l
infantum
lem
l
major
l
amazonensi
antiplasmodium
falciparum
antihb
monoclon
antibodi
contain
ascit
ascit
induc
inject
myeloma
cell
simultan
experiment
infect
induc
control
mice
use
either
l
major
l
amazonensi
confirm
infect
parasit
result
protect
immun
assay
examin
monoclon
antibodi
respect
isotyp
target
antigen
belong
igg
isotyp
iggi
other
iggzb
base
observ
strong
fluoresc
label
l
major
l
amazonensi
live
promastigot
surfac
select
one
monoclon
antibodi
isotyp
potenti
protect
fig
indic
pretreat
two
leishmania
speci
abolish
capac
induc
fig
cutan
leishmaniasi
promastigot
strain
pretreat
ant
ltzshmanta
monoclon
antibodi
control
monoclonai
antibodi
bi
cutan
infect
ascit
fluid
contain
monoclon
antibodi
p
falciparum
hb
whether
decompl
prevent
experiment
infect
complet
protect
observ
three
month
even
though
mani
promastigot
inject
tabl
lesion
appear
control
two
month
infect
lesion
size
cm
three
month
cm
anim
die
six
month
infect
use
giemsa
stain
confirm
lesion
due
leishmaniasi
seen
anoth
viva
system
describ
elsewher
monjour
et
al
antileishmani
monoclon
antibodi
rais
old
world
strain
afford
protect
new
world
leishmania
includ
l
donovani
cross
protect
confirm
data
use
l
major
l
amazunensi
balbic
femal
mice
protect
immun
assay
recent
studi
prove
antibodi
could
import
develop
immun
leishmaniasi
abolish
capac
l
major
multipli
within
macrophag
vitro
handman
hock
provid
protect
l
mexicana
mfection
mice
anderson
et
al
experi
demonstr
singl
monoclon
antibodi
rais
l
infantum
prevent
develop
one
strain
l
major
one
l
mexicana
amazonensi
mechan
confer
possibl
resist
leishmania
infect
frequent
discuss
diseas
consid
control
cellmedi
immun
mauel
behin
recent
studi
suggest
addit
cooper
humor
antibodi
could
play
import
part
effect
protect
arrendondo
perez
alexand
phillip
furthermor
howard
et
al
prophylact
immun
experiment
leishmaniasi
note
antibodi
respons
may
crucial
resist
infect
consid
develop
cellmedi
immun
immun
might
necessari
present
time
handman
hock
anderson
et
al
report
antibodi
use
vitro
vivo
system
abolish
develop
parasit
role
complement
c
effect
controversi
prove
antibodi
c
caus
lysi
promastigot
adler
experi
decompl
monoclon
antibodi
ascit
abl
prevent
leishmania
infect
howev
anderson
et
al
use
one
antibodi
isotyp
igg
suggest
mechan
antibodymedi
protect
may
c
independ
final
accord
handman
hock
isotyp
igg
b
promot
l
major
kill
vitro
isotyp
iggra
igg
cytotox
promastigot
presenc
complement
last
observ
confirm
sever
vivo
system
distinguish
mechan
antibodi
protect
use
may
allow
identif
leishntania
antigen
induc
effect
immun
